Anzeige
Erschienen in:
11.04.2024 | Original Article
Clinical results in patients affected by moderate–severe knee osteoarthritis and treated with micro-fragmented adipose tissue: the therapeutic effects on symptomatology
Erschienen in: MUSCULOSKELETAL SURGERY | Ausgabe 2/2024
Einloggen, um Zugang zu erhaltenAbstract
Osteoarthrosis is a degenerative musculoskeletal disease that presents a major public health problem, due to the increasing average age of the active population, as well as the increasing percentage of obesity or overweight of the general population. New therapeutic approaches have been developed, such as regenerative medicine that uses mesenchymal stromal cells taken from adipose tissue. This study analyzed the clinical potential benefits of using autologous adipose tissue to treat patients with moderate–severe knee osteoarthritis.
In 2021, a total of 50 knees, affected by moderate–severe knee osteoarthritis, were treated with an intra-articular injection of micro-fragmented subcutaneous adipose tissue. Patients were submitted to the KOOS questionnaire before the operation and one year after the operation and VAS pain score at time 0, 3, 6, 12 months.
Of the 50 patients treated, 2 patients were excluded from the study. Of the remaining 48 patients, improvements have been achieved in all subclasses of KOOS. In particular, VAS score proves that improvements are more considerable starting from the 3rd month after surgery.
The results obtained in this study show the safety and potential benefit of the use of autologous micro-fragmented adipose on people who are affected by moderate–severe knee osteoarthritis.